Brownlie Keith L 4
4 · Celldex Therapeutics, Inc. · Filed Jun 9, 2025
Insider Transaction Report
Form 4
Brownlie Keith L
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2025-06-05+16,500→ 16,500 totalExercise: $19.53From: 2026-06-05Exp: 2035-06-05→ Common Stock (16,500 underlying)
Footnotes (1)
- [F1]Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan.